What is ANI Pharmaceuticals's share buybacks?

ANI Pharmaceuticals (ANIP) reported share buybacks of $19.76M in Q1 2026.

How has ANI Pharmaceuticals's share buybacks changed year-over-year?

ANI Pharmaceuticals's share buybacks increased by 97.5% year-over-year, from $10M to $19.76M.

What is the long-term trend for ANI Pharmaceuticals's share buybacks?

Over 4 years (2021 to 2025), ANI Pharmaceuticals's share buybacks has grown at a 92.5% compound annual growth rate (CAGR), from $890K to $12.21M.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

ANI Pharmaceuticals ANIP Share Buybacks

Share Buybacks at other companies

ViatrisVTRS

$0-100%

AnaptysBio, Inc.ANAB

$0-100%

Aurinia PharmaceuticalsAUPH

$36.17M-22.9%

Catalyst PharmaceuticalCPRX

$14.57M+130%

United TherapeuticsUTHR

$1.5B—

Cardinal HealthCAH

$250M-33.3%

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's share buybacks?: ANI Pharmaceuticals (ANIP) reported share buybacks of $19.76M in Q1 2026.
How has ANI Pharmaceuticals's share buybacks changed year-over-year?: ANI Pharmaceuticals's share buybacks increased by 97.5% year-over-year, from $10M to $19.76M.
What is the long-term trend for ANI Pharmaceuticals's share buybacks?: Over 4 years (2021 to 2025), ANI Pharmaceuticals's share buybacks has grown at a 92.5% compound annual growth rate (CAGR), from $890K to $12.21M.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.